China SXT Pharmaceuticals, Inc. - SXTC Earnings per share for the trailing year

China SXT Pharmaceuticals (SXTC) production relies on PRC state aid and strict GMP standards, creating a formidable barrier for external players. This daily price action on GURU.Markets captures the EPS at 97.70. The company attracts experienced chemists through comprehensive benefits packages, while its resilience to global crises and stable demand for pharmaceuticals transform the asset into a defensive tool.
China SXT Pharmaceuticals, Inc. - analytical breakdowns and key metrics (SXTC)

This indicator measures the annual change in net income per share, utilizing a twelve-month rolling window to neutralize seasonality. Daily recalculations of the TTM annual net income per share growth rate reveal hidden trends between quarterly reports while filtering out market noise. A positive vector indicates an increase in the business's fundamental value. For China SXT Pharmaceuticals (SXTC), this confirms the effectiveness of implementing ESG standards and optimizing energy costs in the production of traditional medicines.